wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41668880-FB72D005-A8ED-44E3-A551-3F3A518CAAF3
Q41668880-FB72D005-A8ED-44E3-A551-3F3A518CAAF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41668880-FB72D005-A8ED-44E3-A551-3F3A518CAAF3
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.
P2860
Q41668880-FB72D005-A8ED-44E3-A551-3F3A518CAAF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41668880-FB72D005-A8ED-44E3-A551-3F3A518CAAF3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
992cb25eab71b8a7933ebaed08b714c7edb64f11
P2860
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.